Discover 454 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 454
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
1 location in Little Rock
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
1 location in Little Rock
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
1 location in Little Rock
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
for
Juvenile Psoriatic Arthritis
1 location in Little Rock
Sponsor: AbbVie
Sex: All
Age: 5 - 17
Code: NCT06100744
Phase3, Recruiting
Active & Responsive
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
for
Dravet Syndrome
1 location in Little Rock
Sponsor: Stoke Therapeutics, Inc
Sex: All
Age: 2 - 17
Code: NCT06872125
Phase3, Recruiting
Active & Responsive
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
for
Lymphoblastic Leukemia
1 location in Little Rock
Sponsor: Tanja Andrea Gruber
Sex: All
Age: 0 - 1
Code: NCT05848687
Phase1, Phase2, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma